Evidence map›Paper›PMID 35040104›Full record

ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2022

Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors.

Ebrahim Saeedian Moghadam, Abdullah Mohammed Al-Sadi, Meysam Talebi, Massoud Amanlou, Mohsen Amini, Raid Abdel-Jalil

Open access · greenAbstract read
In one paragraph

Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ebrahim Saeedian MoghadamDepartment of Chemistry, College of Science, Sultan Qaboos University, P.O. Box 36, P.C. 123, Muscat, Sultanate of Oman.
Abdullah Mohammed Al-SadiDepartment of Crop Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, Muscat, Oman.
Meysam TalebiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, 1417614411, Tehran, Iran.
Massoud AmanlouDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, 1417614411, Tehran, Iran.
Mohsen AminiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, 1417614411, Tehran, Iran. moamini@tums.ac.ir.
Raid Abdel-JalilDepartment of Chemistry, College of Science, Sultan Qaboos University, P.O. Box 36, P.C. 123, Muscat, Sultanate of Oman. jalil@squ.edu.om.
Sultan Qaboos University · OMTehran University of Medical Sciences · IR

Funding

His Majesty Trust Fund SR/SCI/CHEM/19/01
6 · The paper itself

Abstract

backgroundBenzimidazole derivatives are widely used to design and synthesize novel bioactive compounds. There are several approved benzimidazole-based drugs on the market.

objectivesIn this study, we aimed to design and synthesize a series of novel benzimidazole derivatives 8a-n that are urease inhibitors.

methodsAll 8a-n were synthesized in a multistep. To determine the urease inhibitory effect of 8a-n, the urease inhibition kit was used. The cytotoxicity assay of 8a-n was determined using MTT method. Molecular modelling was determined using autodock software.

resultsAll 8a-n were synthesized in high yield, and their structures were determined using

conclusionThe synthesized benzimidazole derivatives exhibit high activity, suggesting that further research on this family of compounds would be beneficial to finding a potent urease inhibitor.

Indexed as

Enzyme InhibitorsUreaseBenzimidazolesMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipBenzimidazolesEnzyme InhibitorsUreaseBenzimidazoleDrug designNitrogen heterocyclesSynthesisUrease inhibitors

Identifiers

PMID35040104
PMCPMC9114190
OpenAlexW4205401363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.